| Product Code: ETC10939627 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Vaccine Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Vaccine Market - Industry Life Cycle |
3.4 Sweden Vaccine Market - Porter's Five Forces |
3.5 Sweden Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Sweden Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Sweden Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Sweden Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Sweden Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives for vaccination programs |
4.2.2 Growing awareness about the importance of vaccines in Sweden |
4.2.3 Technological advancements in vaccine development and production |
4.3 Market Restraints |
4.3.1 Vaccine hesitancy among certain population groups |
4.3.2 Stringent regulatory requirements for vaccine approval |
4.3.3 Limited access to healthcare services in remote areas |
5 Sweden Vaccine Market Trends |
6 Sweden Vaccine Market, By Types |
6.1 Sweden Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Sweden Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F |
6.1.4 Sweden Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F |
6.1.5 Sweden Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F |
6.2 Sweden Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Sweden Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.3 Sweden Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F |
6.2.4 Sweden Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F |
6.3 Sweden Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Sweden Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F |
6.3.3 Sweden Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.3.4 Sweden Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F |
6.4 Sweden Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Sweden Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4.3 Sweden Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.4 Sweden Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Sweden Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Sweden Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F |
6.5.3 Sweden Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F |
6.5.4 Sweden Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F |
7 Sweden Vaccine Market Import-Export Trade Statistics |
7.1 Sweden Vaccine Market Export to Major Countries |
7.2 Sweden Vaccine Market Imports from Major Countries |
8 Sweden Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rate |
8.2 Number of vaccines in the national immunization schedule |
8.3 Research and development investments in vaccine technologies |
9 Sweden Vaccine Market - Opportunity Assessment |
9.1 Sweden Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Sweden Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Sweden Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Sweden Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Sweden Vaccine Market - Competitive Landscape |
10.1 Sweden Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Sweden Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here